Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor necrosis factor: how to improve the antitumor activity and decrease accompanying side effects for therapeutic

K Haranaka1

  • 1Department of Internal Medicine, University of Tokyo, Japan.

Journal of Biological Response Modifiers
|December 1, 1988
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Purification, characterization and anti-tumor activity of a new cytokine, histiocyte-secreted-factor (HSF).

International journal of cancer·1996
Same author

Combination therapy with traditional Chinese medicines and Streptococcus pyogenes products (OK 432) for endogenous tumor necrosis factor therapy. A preliminary report.

Cancer biotherapy·1995
Same author

Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia against heterotransplanted human prostatic carcinoma and its lymph node metastasis in nude mice.

Molecular biotherapy·1992
Same author

Antiproliferative and proliferative effects of TNF on normal and tumor cells.

Biotherapy (Dordrecht, Netherlands)·1991
Same author

Preventive effect of several drugs against Pseudomonas aeruginosa infection and the toxicity of combined tumor necrosis factor with lipopolysaccharide: relationship between lethality and the arachidonic cascade.

Biotherapy (Dordrecht, Netherlands)·1990
Same author

Therapy combining tumor necrosis factor with tumor-specific antibody against Meth A sarcoma.

Journal of biological response modifiers·1989